ABSTRACT
El objetivo del presente trabajo ha sido verificar mediante análisis ergonómico, si el puesto de trabajo de un cajero con deficiencia física y grave compromiso de la función motora de miembros inferiores estaba adaptado a sus características. Se elaboró un protocolo de análisis ergonómico personalizado, con observación y mediciones del proceso, ambiente de trabajo y entrevistas semiestructuradas. El estudio del caso se realizó en una empresa de transportes del sector minorista de Joao Pessoa, del estado de Paraíba en Brasil, constatándose que el puesto de trabajo reseñado, no estaba adecuado a las características del trabajador objeto de estudio. Los mayores problemas se encontraron en la accesibilidad dentro del lugar de trabajo, mobiliario del puesto y disposición de los equipamientos, que se encontraron inadecuados, favoreciendo posturas y movimientos de riesgo, que contribuyen a agravar la deficiencia física existente y la aparición de nuevas incapacidades
The aim of the present study was to verify, through ergonomic analysis of the work, if the job occupied by a working teller with serious commitment of the motor function in the lower limbs, was ergonomically adapted to the special characteristics of the same one. An ergonomic protocol of analysis of the work adapted to the study for this person was elaborated, it consited in direct and sistematical observation of the process and the atmosphere of work; the study of the case was made in one of the ships of a great company of transport of the retail sector in Brazil. Being stated that the analyzed job was not suitable to the particular characteristics of the working object of the study. The greater problems were in the accessibility within the own place of work, in the furniture and the disposition of the equipment, that were inadequate, favoring positions of risks
Subject(s)
Male , Adult , Humans , Disabled Persons , 16359 , 16360 , Ergonomics , Occupational HealthABSTRACT
Corynebacterium pseudotuberculosis is a gram-positive bacterium that causes caseous lymphadenitis in sheep and goats. However, despite the economic losses caused by caseous lymphadenitis, there is little information about the molecular mechanisms of pathogenesis of this bacterium. Genomic libraries constructed in bacterial artificial chromosome (BAC) vectors have become the method of choice for clone development in high-throughput genomic-sequencing projects. Large-insert DNA libraries are useful for isolation and characterization of important genomic regions and genes. In order to identify targets that might be useful for genome sequencing, we constructed a C. pseudotuberculosis BAC library in the vector pBeloBAC11. This library contains about 18,000 BAC clones, with inserts ranging in size from 25 to 120 kb, theoretically representing a 390-fold coverage of the C. pseudotuberculosis genome (estimated to be 2.5-3.1 Mb). Many genomic survey sequences (GSSs) with homology to C. diphtheriae, C. glutamicum, C. efficiens, and C. jeikeium proteins were observed within a sample of 215 sequenced clones, confirming their close phylogenetic relationship. Computer analyses of GSSs did not detect chimeric, deleted, or rearranged BAC clones, showing that this library has low redundancy. This GSSs collection is now available for further genetic and physical analysis of the C. pseudotuberculosis genome. The GSS strategy that we used to develop our library proved to be efficient for the identification of genes and will be an important tool for mapping, assembly, comparative, and functional genomic studies in a C. pseudotuberculosis genome sequencing project that will begin this year.
Subject(s)
Corynebacterium pseudotuberculosis/genetics , Chromosomes, Artificial, Bacterial/genetics , Chromosomes, Bacterial/genetics , Gene Library , Genome, Bacterial/genetics , Cloning, Molecular , Sequence Analysis, DNAABSTRACT
Progress in schistosome genome research has enabled investigators to move rapidly from genome sequences to vaccine development. Proteins bound to the surface of parasites are potential vaccine candidates, or they can be used for diagnosis. We analyzed 4342 proteins deduced from the Schistosoma mansoni transcriptome with bioinformatic computer programs. Thirty-four proteins had membrane-bound motifs. Within this group, we selected the Sm29 protein to be further characterized by in silico analysis. Sm29 was found to have a signal peptide made up of 26 amino acids, with a cleavage site between Ser26 and Val27. The glycosylation site search revealed three threonines (39, 132 and 133) with high probability of O-glycosylation and two asparagines (58 and 115) with high probability of N-glycosylation. Only one transmembrane helix was found in the C-terminal region of the protein from Leu169 to Lis191. The search for similarities and conserved motifs show that Sm29 is a protein with high identity to proteins present in S. japonicum (53, 52, 49, and 37% of identity) and it possesses disulfide-rich conserved domains. Apparently, Sm29 is a membrane bound protein, and it may be an important molecule in host-parasite interactions.
Subject(s)
Animals , Membrane Glycoproteins/isolation & purification , Helminth Proteins/isolation & purification , Schistosoma mansoni/genetics , Transcription, Genetic , Amino Acid Sequence , Computational Biology , Genomics , Membrane Glycoproteins/genetics , Molecular Sequence Data , Helminth Proteins/genetics , Schistosoma mansoni/chemistryABSTRACT
Lactococcus lactis, the model lactic acid bacterium, is a good candidate for heterologous protein production in both foodstuffs and the digestive tract. We attempted to produce Streptomyces tendae antifungal protein 1 (Afp1) in L. lactis with the objective of constructing a strain able to limit fungal growth. Since Afp1 activity requires disulfide bond (DSB) formation and since intracellular redox conditions are reportedly unfavorable for DSB formation in prokaryotes, Afp1 was produced as a secreted form. An inducible expression-secretion system was used to drive Afp1 secretion by L. lactis; Afp1 was fused or not with LEISSTCDA, a synthetic propeptide (LEISS) that has been described to be a secretion enhancer. Production of Afp1 alone was not achieved, but production of LEISS-Afp1 was confirmed by Western blot and immunodetection with anti-Afp1 antibodies. This protein (molecular mass: 9.8 kDa) is the smallest non-bacteriocin heterologous protein ever reported to be secreted in L. lactis via the Sec-dependent pathway. However, no anti-fungal activity was detected, even in concentrated samples of induced supernatant. This could be due to a too low secretion yield of Afp1 in L. lactis, to the absence of DSB formation, or to an improper DSB formation involving the additional cysteine residue included in LEISS propeptide. This raises questions about size limits, conformation problems, and protein secretion yields in L. lactis.
Subject(s)
Lactococcus lactis/metabolism , Bacterial Proteins , Carrier Proteins , Antifungal Agents/isolation & purification , Antifungal Agents/metabolism , Antifungal Agents/pharmacology , Aspergillus fumigatus/drug effects , Blotting, Western , Microbial Sensitivity Tests , Paecilomyces/drug effects , Plasmids/genetics , Bacterial Proteins/genetics , Bacterial Proteins/pharmacology , Carrier Proteins/genetics , Carrier Proteins/pharmacology , Trichophyton/drug effectsABSTRACT
Paramyosin and Sm14 are two of the six antigens selected by the World Health Organization as candidates to compose a subunit vaccine against schistosomiasis. Both antigens are recognized by individuals naturally resistant to Schistosoma mansoni infection and induced protective immunity in the murine model. Three Sm14 epitopes and eleven paramyosin epitopes were selected by their ability to bind to different HLA-DR molecules using the TEPITOPE computer program, and these peptides were synthetically produced. The cellular recognition of Sm14 and paramyosin epitopes by peripheral blood mononuclear cells of individuals living in endemic area for schistosomiasis was tested by T cell proliferation assay. Among all Sm14 and paramyosin epitopes studied, Sm14-3 was preferentially recognized by individuals naturally resistant to S. mansoni infection while Para-5 was preferentially recognized by individuals resistant to reinfection. These two peptides represent promising antigens to be used in an experimental vaccine against schistosomiasis, since their preferential recognition by resistant individuals suggest their involvement in the induction of protective immunity.
Subject(s)
Humans , Animals , Male , Female , Antigens, Helminth , Schistosoma mansoni , Schistosomiasis mansoni , Tropomyosin , Vaccines , Algorithms , Epitopes , HLA-DR Antigens , Leukocytes, Mononuclear , T-LymphocytesABSTRACT
Chromobacterium violaceum is a versatile, Gram-negative beta-protebacterium that grows in a variety of ecosystems in tropical and subtropical areas, such as the water and borders of the Negro River, in the Amazon region of Brazil. Although it is a saprophyte and is generally considered non-pathogenic, sporadic cases of human infection have been described, mainly in young children and in immunodeficient individuals. Although rare, infections with C. violaceum are characterized by rapid dissemination and high mortality. With the complete genome sequence of C. violaceum now available, a detailed description of the molecular arsenal required for this bacterium's remarkable versatility has been revealed. Most importantly, a more detailed picture of its biotechnological properties, including the characteristic violacein pigment, has emerged. The complete genome sequence also enabled us to make a thorough examination of the repertoire of genes encoding probable virulence factors, which determine the potential for pathogenesis. We described a number of genes involved in infectious processes, such as host cell adhesion, [quot ]contact-dependent secretion[quot ] of factors that promote cell invasion, as well as other virulence factors, such as cytolytic proteins. We also described genes involved with the synthesis of lipopolysaccharides and proteoglycan, known to elicit the synthesis of pro-inflammatory cytokines and involved in the detoxification process, which may contribute to the evasion of the bacteria from the host immune response
Subject(s)
Chromobacterium/genetics , Virulence Factors/genetics , Genome, Bacterial , Lipopolysaccharides/biosynthesis , Bacterial Adhesion/genetics , Chromobacterium/pathogenicity , Colicins/biosynthesis , Colicins/genetics , Hemolysin Proteins/biosynthesis , Hemolysin Proteins/genetics , Indoles , Virulence/geneticsABSTRACT
Lactococcus lactis, the most extensively characterized lactic acid bacterium, is a mesophilic- and microaerophilic-fermenting microorganism widely used for the production of fermented food products. During industrial processes, L. lactis is often exposed to multiple environmental stresses (low and high temperature, low pH, high osmotic pressure, nutrient starvation and oxidation) that can cause loss or reduction of bacterial viability, reproducibility, as well as organoleptic and/or fermentative qualities. Among these stress factors, oxidation can be considered one of the most deleterious to the cell, causing cellular damage at both molecular and metabolic levels. During the last two decades, considerable efforts have been made to improve our knowledge of oxidative stress in L. lactis. Many genes involved with both oxidative stress resistance and control mechanisms have been identified; functionally they seem to overlap. The finding of new genes, and a better understanding of the molecular mechanisms of stress resistance in L. lactis and other lactic acid bacterium, will lead to the construction and isolation of stress-resistant strains. Such strains could be exploited for both traditional and probiotic uses
Subject(s)
Oxidative Stress/physiology , Lactococcus lactis/metabolism , Multienzyme Complexes/metabolism , Oxidative Stress/genetics , Genes, Bacterial/genetics , Lactococcus lactis/genetics , NADH, NADPH Oxidoreductases/metabolism , Peroxidases/metabolism , Rec A Recombinases/metabolism , Cell Survival/genetics , Superoxide Dismutase/metabolismABSTRACT
Lactic acid bacteria (LAB), widely used in the food industry, are present in the intestine of most animals, including humans. The potential use of these bacteria as live vehicles for the production and delivery of heterologous proteins of vaccinal, medical or technological interest has therefore been extensively investigated. Lactococcus lactis, a LAB species, is a potential candidate for the production of biologically useful proteins. Several delivery systems have been developed to target heterologous proteins to a specific cell location (i.e., cytoplasm, cell wall or extracellular medium). A promising application of L. lactis is its use as an antigen delivery vehicle, for the development of live mucosal vaccines. The expression of heterologous proteins and antigens as well as the various delivery systems developed in L. lactis, and its use as an oral vaccine carrier are discussed
Subject(s)
Animals , Genetic Vectors , Lactococcus lactis/genetics , Vaccines , Antigens/genetics , Antigens/metabolism , Cytokines/genetics , Cytokines/metabolism , Gene Expression Regulation , Immunity, Mucosal , Lactococcus lactis/metabolism , Mice , Recombinant Proteins/genetics , Recombinant Proteins/metabolismABSTRACT
Sm14 is a 14-kDa vaccine candidate antigen from Schistosoma mansoni that seems to be involved in cytoplasmic trafficking of fatty acids. Although schistosomes have a high requirement for lipids, they are not able to synthesize fatty acids and sterols de novo. Thus, they must acquire host lipids. In order to determine whether Sm14 is present in different stages of the life cycle of the parasite, we performed RT-PCR. Sm14 mRNA was identified in all stages of the life cycle studied, mainly schistosomulum, adult worm and egg. Additionally, we used a rabbit anti-Sm14 polyclonal antibody in an indirect immunofluorescence assay to localize Sm14 in adult worm sections. The basal lamella of the tegument and the gut epithelium were strongly labeled. These tissues have a high flow of and demand for lipids, a finding that supports the putative role of Sm14 as an intracellular transporter of fatty acids from host cells
Subject(s)
Animals , Male , Female , Mice , Rabbits , Helminth Proteins , Schistosoma mansoni , Schistosomiasis mansoni , Antibodies, Helminth , Carrier Proteins , DNA, Complementary , Fluorescent Antibody Technique, Indirect , Gene Expression , Helminth Proteins , Life Cycle Stages , Mice, Inbred BALB C , Reverse Transcriptase Polymerase Chain Reaction , Schistosoma mansoni , VaccinesABSTRACT
DNA-based immunization has initiated a new era of vaccine research. One of the main goals of gene vaccine development is the control of the levels of expression in vivo for efficient immunization. Modifying the vector to modulate expression or immunogenicity is of critical importance for the improvement of DNA vaccines. The most frequently used vectors for genetic immunization are plasmids. In this article, we review some of the main elements relevant to their design such as strong promoter/enhancer region, introns, genes encoding antigens of interest from the pathogen (how to choose and modify them), polyadenylation termination sequence, origin of replication for plasmid production in Escherichia coli, antibiotic resistance gene as selectable marker, convenient cloning sites, and the presence of immunostimulatory sequences (ISS) that can be added to the plasmid to enhance adjuvanticity and to activate the immune system. In this review, the specific modifications that can increase overall expression as well as the potential of DNA-based vaccination are also discussed
Subject(s)
Genetic Vectors , Vaccines, DNA , Enhancer Elements, Genetic , Promoter Regions, GeneticABSTRACT
The use of mammalian gene expression vectors has become increasingly important for genetic immunization and gene therapy as well as basic research. Essential for the success of these vectors in genetic immunization is the proper choice of a promoter linked to the antigen of interest. Many genetic immunization vectors use promoter elements from pathogenic viruses including SV40 and CMV. Lymphokines produced by the immune response to proteins expressed by these vectors could inhibit further transcription initiation by viral promoters. Our objective was to determine the effect of IFN-g on transgene expression driven by viral SV40 or CMV promoter/enhancer and the mammalian promoter/enhancer for the major histocompatibility complex class I (MHC I) gene. We transfected the luciferase gene driven by these three promoters into 14 cell lines of many tissues and several species. Luciferase assays of transfected cells untreated or treated with IFN-g indicated that although the viral promoters could drive luciferase production in all cell lines tested to higher or lower levels than the MHC I promoter, treatment with IFN-g inhibited transgene expression in most of the cell lines and amplification of the MHC I promoter-driven transgene expression in all cell lines. These data indicate that the SV40 and CMV promoter/enhancers may not be a suitable choice for gene delivery especially for genetic immunization or cancer cytokine gene therapy. The MHC I promoter/enhancer, on the other hand, may be an ideal transgene promoter for applications involving the immune system
Subject(s)
Gene Expression Regulation , Genetic Vectors , Transgenes , Vaccines, DNA , Cytomegalovirus , Enhancer Elements, Genetic , Genes, MHC Class I , Luciferases , Promoter Regions, Genetic , Simian virus 40ABSTRACT
Gene vaccines represent a new and promising approach to control infectious diseases, inducing a protective immune response in the appropriate host. Several routes and methods of genetic immunization have been shown to induce antibody production as well as T helper (Th) cell and cytotoxic T lymphocyte activation. However, few studies have compared the nature of the immune responses generated by different gene vaccination delivery systems. In the present study we reviewed some aspects of immunity induced by gene immunization and compared the immune responses produced by intramuscular (im) DNA injection to gene gun-mediated DNA transfer into the skin of BALB/c mice. Using a reporter gene coding for ß-galactosidase, we have demonstrated that im injection raised a predominantly Th1 response with mostly IgG2a anti-ßgal produced, while gene gun immunization induced a mixed Th1/Th2 profile with a balanced production of IgG2a and IgG1 subclasses. Distinct types of immune responses were generated by different methods of gene delivery. These findings have important implications for genetic vaccine design. Firstly, a combination between these two systems may create optimal conditions for the induction of a broad-based immune response. Alternatively, a particular gene vaccine delivery method might be used according to the immune response required for host protection. Here, we describe the characteristics of the immune response induced by gene vaccination and the properties of DNA involved in this process
Subject(s)
Animals , Mice , Genes , Immunotherapy, Active/methods , Vaccines, DNA/immunology , Biolistics , Gene Transfer Techniques , Mice, Inbred BALB CABSTRACT
Cellular immune responses are a critical part of the host's defense against intracellular bacterial infections. Immunity to Brucella abortus crucially depends on antigen-specific T cell-mediated activation of macrophages, which are the major effectors of cell-mediated killing of this organism. T lymphocytes that proliferate in response to B. abortus were characterized for phenotype and cytokine activity. Human, murine, and bovine T lymphocytes exhibited a type 1 cytokine profile, suggesting an analogous immune response in these different hosts. In vivo protection afforded by a particular cell type is dependent on the antigen presented and the mechanism of antigen presentation. Studies using MHC class I and class II knockout mice infected with B. abortus have demonstrated that protective immunity to brucellosis is especially dependent on CD8+ T cells. To target MHC class I presentation we transfected ex vivo a murine macrophage cell line with B. abortus genes and adoptively transferred them to BALB/c mice. These transgenic macrophage clones induced partial protection in mice against experimental brucellosis. Knowing the cells required for protection, vaccines can be designed to activate the protective T cell subset. Lastly, as a new strategy for priming a specific class I-restricted T cell response in vivo, we used genetic immunization by particle bombardment-mediated gene transfer.
Subject(s)
Mice , Animals , Bacterial Infections/physiopathology , Cytokines/physiology , In Vitro Techniques , T-Lymphocyte Subsets/pathology , T-Lymphocyte Subsets/physiologyABSTRACT
Pancreatite hereditaria (PH) é uma causa rara de pancreatite crônica cuja manifestaçäo clínica mais comum é a dor abdominal recorrente que se inicia na infância ou na adolescência. OBJETIVO. Relatar um caso de PH com apresentaçäo atipica e revisäo da literatura. MÉTODOS. Estudou-se um paciente näo etilista, sem história de dor abdominal, que apresentava quadro de esteatorréia e desnutriçäo. A investigaçäo diagnóstica revelou a presença de pancreatite crônica avançada. Dois outros casos semelhantes foram detectados na família. Aspectos clínicos e epidemiológicos desta entidade foram revisados. CONCLUSäO. PH, embora incomum, deve fazer parte do diagnóstico diferencial das pancreatites crônicas, efetuando-se a triagem familiar diante da suspeita clínica